Prostate cancer is one of those conditions where treatment is never “one-size-fits-all.” Anyone who has spent time in a urology clinic sees this quickly. Two patients with similar reports can end up on completely different paths (Medical and Surgical). That is not confusion, it is precision medicine in action.
At Urologic Health Dubai, where we focus on evidence-based care and real-world outcomes, I have seen how outcomes improve when decisions are made early, structured, and based on risk level, not fear.
The truth is simple. Treatment is built around stage, biology of the tumor, age, and overall health. Sometimes the best treatment is no immediate treatment at all.
Understanding Treatment Planning in Prostate Cancer
Before anything is decided, doctors go through treatment planning carefully. This is where the real direction of care is formed.
A full evaluation usually includes:
| Test | Why it matters |
|---|---|
| PSA blood test | Tracks PSA level changes over time |
| Digital Rectal Exam (DRE) | Checks prostate size and irregularities |
| MRI / mpMRI | Shows tumor location and spread |
| Biopsy | Confirms cancer type and Gleason score |
| Imaging scans | Checks metastasis or lymph node involvement |
The goal is not just finding cancer, but understanding how aggressive it is.
For example:
- Gleason score 3+3 (Grade Group 1) often behaves slowly
- High PSA density or rapid PSA doubling time suggests aggressive disease
- Clinical staging like T1c or T2a helps define spread
This is where guidelines like NCCN (National Comprehensive Cancer Network) help standardize decisions across global urology practice.
Active Surveillance for Prostate Cancer (When Treatment Is Not Immediate)
There is a misconception that cancer always requires surgery right away. That is not true for every case.
Active Surveillance for Prostate Cancer is often recommended for low-risk disease, especially when cancer is slow-growing and confined.
This approach is based on strict monitoring:
- PSA tests every 3–6 months
- Digital rectal exams (DRE) regularly
- Repeat biopsies over time
- mpMRI scans when needed
Doctors watch for cancer progression, not immediate treatment.
Typical candidates include:
- Very-low-risk or low-risk disease
- PSA level under 10 ng/mL
- Small tumor volume (T1c or T2a)
- Life expectancy more than 10 years or sometimes less depending on comorbidities
Some patients stay stable for 6 months, 12 months, or even 24 months without needing intervention.
But here is the hard truth most clinics do not explain well: surveillance only works if follow-up is strict. Miss monitoring, and you lose control of timing.
Surgery for Prostate Cancer: When Removal Becomes Necessary
When cancer is localized but higher risk, prostate cancer surgery becomes a curative option.
The main procedure is radical prostatectomy, also called prostatectomy.
Types of prostate surgery
| Type | Description |
|---|---|
| Open prostatectomy | Traditional incision in lower abdomen |
| Laparoscopic prostatectomy | Small keyhole surgery with camera |
| Robotic prostatectomy | Uses da Vinci surgical system and robotic arms |
In modern centers, robotic prostatectomy dominates because of precision and reduced blood loss.
What actually happens in surgery
During prostatectomy, the surgeon removes:
- Prostate gland
- Seminal vesicles
- Sometimes lymph nodes (pelvic lymph node dissection)
The surgery is done under general anesthesia using advanced surgical tools or robotic arms with magnified 3D visualization.
Recovery is not instant:
- Hospital stay: usually 1–2 days
- Catheter use: about 1–2 weeks
- Full recovery: 4–6 weeks
Risks that cannot be ignored
Even in expert hands:
- Urinary incontinence can occur
- Erectile dysfunction is possible due to nerve damage
- Blood loss, infection, and scarring are surgical risks
Nerve-sparing techniques reduce damage, but they do not eliminate risk completely.
Rehabilitation may include:
- Pelvic floor exercises (Kegel exercises)
- PDE-5 inhibitors like sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)
- Vacuum erection devices
- Sometimes penile implants in severe cases
Fertility is often affected, so sperm banking may be discussed before surgery.
External Beam Radiation Therapy for Prostate Cancer
External beam radiation therapy (EBRT) is one of the most common non-surgical options.
It uses high-energy X-rays or proton beams delivered by a machine over several weeks.
Common techniques:
- IMRT (Intensity-Modulated Radiation Therapy)
- 3D-CRT (3D conformal radiation therapy)
- SBRT (Stereotactic body radiotherapy)
- Proton beam therapy
Treatment is usually:
- 5 days a week
- For several weeks
It works well for localized or locally advanced disease, and sometimes metastatic bone pain.
Side effects include:
- Frequent urination
- Painful urination
- Rectal irritation or bleeding
- Erectile dysfunction
Long-term data shows disease control improves when combined with hormone therapy (ADT) in intermediate and high-risk cases.
Brachytherapy for Prostate Cancer: Internal Radiation
Brachytherapy is internal radiation where radioactive seeds are placed directly inside the prostate gland.
It can be:
- Low dose rate (LDR) permanent seeds
- High dose rate (HDR) temporary radiation
A transperineal approach is used with ultrasound guidance.
Advantages:
- High local control
- Short treatment time
- Outpatient or short hospital stay
Side effects:
- Urinary burning
- Frequency
- Temporary bowel issues
- Erectile dysfunction in some cases
It is usually best for localized prostate cancer, not advanced disease.
Ablation Therapy for Prostate Cancer
Ablation uses extreme temperatures to destroy cancer cells.
Methods include:
- Cryotherapy (freezing)
- High-Intensity Focused Ultrasound (HIFU)
Thin probes are inserted into the prostate through the perineum.
This is minimally invasive and often used when:
- Surgery is not suitable
- Radiation has failed
- Cancer is localized or intermediate risk
Risks:
- Urinary incontinence
- Erectile dysfunction
- Tissue damage to nearby structures
It is still considered evolving in many guidelines, though increasingly used in selected cases.
Hormone Therapy for Prostate Cancer (ADT)
Hormone therapy, also called androgen deprivation therapy (ADT), reduces testosterone that fuels cancer growth.
It includes:
- LHRH agonists and antagonists
- Anti-androgens
- Surgical castration (rare today)
Drugs include leuprolide, degarelix, enzalutamide, abiraterone, and others.
It is widely used in:
- Advanced prostate cancer
- Metastatic disease
- Combination with radiation or surgery
Side effects are significant:
- Hot flashes
- Weight gain
- Loss of muscle
- Reduced libido
- Bone thinning (osteoporosis)
- Metabolic and cardiovascular risks
Still, in high-risk patients, it significantly improves survival outcomes.
Chemotherapy for Advanced Prostate Cancer
Chemotherapy is not first-line for early disease.
It is mainly used in:
- Metastatic castration-resistant prostate cancer (mCRPC)
- Hormone therapy failure
Drugs like docetaxel and cabazitaxel are given intravenously in cycles.
Common side effects:
- Fatigue
- Infection risk
- Neuropathy
- Hair loss
- Nausea
It extends survival in advanced cases but is not curative.unotherapy
Modern oncology is shifting toward precision medicine.
Examples:
- PARP inhibitors (olaparib, rucaparib) for DNA repair mutations
- Pembrolizumab in select cases
- Sipuleucel-T immunotherapy
These treatments target cancer biology instead of broadly killing cells.
They are mainly used in:
- Advanced prostate cancer
- Genetic mutation-positive tumors
- Clinical trial settings
Radiopharmaceutical Treatments
One of the most advanced options today is PSMA-targeted therapy.
Example:
- Lutetium-177 PSMA therapy
It delivers radiation directly to prostate cancer cells.
Used in:
- Metastatic disease
- Treatment-resistant cases
It improves pain control and survival in selected patients but is not widely available everywhere.
Final Clinical Perspective
Here is the reality most people miss.
Prostate cancer treatment is not about choosing the “strongest” option. It is about choosing the right sequence.
Some patients need only monitoring under Active Surveillance for Prostate Cancer. Others need immediate radical prostatectomy or radiation therapy. Advanced cases require combinations like hormone therapy, chemotherapy, and targeted drugs.
At centers like Urologic Health Dubai, decisions are made by balancing:
- Cancer aggressiveness
- Patient age and life expectancy
- Side effect tolerance
- Long-term quality of life
The goal is not just survival. It is controlled disease, preserved function, and realistic expectations.
If there is one truth in urologic oncology, it is this: timing matters as much as treatment itself.
